17 Results for "

human MAGL

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "human MAGL" in MCE Product Catalog:

  • Targets Recommended:
3
3 Cited Publications
Cat. No.: HY-18977
CAS No.: 1380424-42-9
Target:  

MAGL

KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12332
CAS No.: 1416133-89-5
Purity:  99.90%
Target:  

MAGL

Research Areas:  

Neurological Disease

JW 642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108613
CAS No.: 1515855-97-6
Purity:  99.55%
Target:  

MAGL

Research Areas:  

Neurological Disease Cancer

JJKK 048 is a highly selective and potent monoacylglycerol lipase (MAGL) inhibitor with IC50 values of 214 pM, 275 pM and 363 pM for human, rat, and mouse MAGL. JJKK 048 displays low cross-reactivity with other endocannabinoid targets. JJKK 048 can be used in the research of diseases such as cancer, neurodegenerative diseases, and pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111538
CAS No.: 2324160-91-8
Purity:  99.78%
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays .
loading...
    loading...
Cat. No.: HY-177093
CAS No.: 2244136-58-9
Synonyms: BMS-986368; CC-97489; ABX-1772
Target:  

MAGL FAAH

Research Areas:  

Neurological Disease

Irafamdastat (BMS-986368) (Example 74) is a FAAH and MAGL inhibitor, with IC50s ≤ 100 nM (human FAAH) and 100 nM-1 μM (human MAGL) respectively. Irafamdastat has antiepileptic effect .
loading...
    loading...
Cat. No.: HY-120851
CAS No.: 1572051-31-0
Purity:  ≥95.0%
Research Areas:  

Metabolic Disease

O-7460 is a potent and selective DAGLα inhibitor, with an IC50 of 0.69 μM. O-7460 shows selectivity over onoacylglycerol lipase (MAGL), human CB1 and CB2 cannabinoid receptors. O-7460 can decrease HFD-caused an up-regulation of 2-AG levels .
loading...
    loading...
Cat. No.: HY-121422
CAS No.: 1680193-80-9
Purity:  99.72%
Target:  

MAGL Histamine Receptor

Research Areas:  

Inflammation/Immunology

JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research .
loading...
    loading...
Cat. No.: HY-163733
CAS No.: 1515855-85-2
Target:  

FAAH MAGL

AKU-005 is a FAAH and MAGL dual inhibitor with IC50 values of 63, 389 nM for rat and human FAAH, respectively. AKU-005 has the potential for the research of trigeminal hyperalgesia .
loading...
    loading...
Cat. No.: HY-150702
CAS No.: 2361575-20-2
Target:  

MAGL

MAGLi 432 is a non-covalent, potent, highly selective, and reversible MAGL inhibitor. MAGLi 432 binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme). MAGLi 432 can be used in the research of chronic inflammation, blood–brain barrier dysfunction, neurological disorders such as multiple sclerosis, Alzheimer’s disease and Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-103463
CAS No.: 1346169-63-8
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

SA57 is a potent, selective FAAH inhibitor with IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH. SA57 also inhibits the 2-arachidonoylglycerol hydrolases MAGL (IC50s of 410 nM and 1.4 μM for mouse and human MAGL) and mouse α/β-hydrolase domain-containing protein 6 (mABHD6; IC50 of 850 nM), but not other brain serine hydrolases .
loading...
    loading...
Cat. No.: HY-124576
CAS No.: 2010154-82-0
Target:  

MAGL

Research Areas:  

Neurological Disease

ABD-1970 is a selective monoacylglycerol lipase (MAGL) inhibitor with IC50s of 15 nM and 29 nM for human and mouse MAGL, respectively. ABD-1970 shows selectivity for MGLL over other members of the serine hydrolase class. ABD-1970 has the potential for the study of neurological disorders .
loading...
    loading...
Cat. No.: HY-116143
CAS No.: 1352011-38-1
Target:  

MAGL

Research Areas:  

Metabolic Disease

SAR127303 is an orally active, selective, competitive monoacylglycerol lipase (MAGL) covalent inhibitor with IC50s of 3.8 nM and 29 nM for mouse and human MAGL, respectively. SAR127303 potently elevates hippocampal levels of 2-AG in mice. SAR127303 decreased long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus. SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain. SAR127303 slows down epileptogenesis .
loading...
    loading...
Cat. No.: HY-182639
CAS No.: 1869033-49-7
Research Areas:  

Cancer

AM9928 is a monoacylglycerol lipase (MAGL) inhibitor with IC50 and Ki values of 8.9 nM and 7.3 nM, respectively. AM9928 blocks the adhesion and migration of triple-negative breast cancer (TNBC) cells, and inhibits the secretion of IL-6, IL-8 and VEGF-A by TNBC cells. AM9928 suppresses the activation of human brain microvascular endothelial cells (HBMECs) induced by TNBC-derived exosomes, and reduces the secretion of IL-8 and VEGF-A by HBMECs. AM9928 attenuates changes in blood-brain barrier permeability, inhibits tumor growth in the mammary fat pad, and reduces brain colonization of TNBC. AM9928 can be used in studies related to triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-108613R
CAS No.: 1515855-97-6
Research Areas:  

Neurological Disease Cancer

JJKK 048 (Standard) is the analytical standard of JJKK 048 (HY-108613). This product is intended for research and analytical applications. JJKK 048 is a highly selective and potent monoacylglycerol lipase (MAGL) inhibitor with IC50 values of 214 pM, 275 pM and 363 pM for human, rat, and mouse MAGL. JJKK 048 displays low cross-reactivity with other endocannabinoid targets. JJKK 048 can be used in the research of diseases such as cancer, neurodegenerative diseases, and pain .
loading...
    loading...
Cat. No.: HY-P701984
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MGLL; Monoglyceride lipase; MGL; HU-K5; Lysophospholipase homolog; Lysophospholipase-like; Monoacylglycerol lipase; MAGL
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701985
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MGLL; Monoglyceride lipase; MGL; HU-K5; Lysophospholipase homolog; Lysophospholipase-like; Monoacylglycerol lipase; MAGL
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-184029
CAS No.: 1020321-13-4
Research Areas:  

Others

PF-7845yne is a clickable analogue of PF-7845. PF-7845yne serves as a pharmacological probe to investigate effects of targeting the FAAH-anandamide pathway .
loading...
    loading...
  • 1